MIM
KYNB

MetLife Investment Management’s Kyntra Bio KYNB Stock Holding History

MetLife Investment Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,200
Closed -$70.5K – 2896
2024
Q1 		$70.5K Buy
+1,200
New +$51.7K ﹤0.01% 2665
2023
Q3 		– Sell
-1,946
Closed -$131K – 2918
2023
Q2 		$131K Buy
1,946
+54
+3% +$22.3K ﹤0.01% 2525
2023
Q1 		$883K Hold
1,892
– – 0.01% 1279
2022
Q4 		$758K Hold
1,892
– – 0.01% 1367
2022
Q3 		$615K Hold
1,892
– – 0.01% 1480
2022
Q2 		$500K Hold
1,892
– – ﹤0.01% 1660
2022
Q1 		$569K Buy
1,892
+674
+55% +$235K ﹤0.01% 1692
2021
Q4 		$429K Buy
1,218
+220
+22% +$68.5K ﹤0.01% 1586
2021
Q3 		$255K Sell
998
-280
-22% -$99.2K ﹤0.01% 1935
2021
Q2 		$851K Hold
1,278
– – 0.01% 1263
2021
Q1 		$1.11M Sell
1,278
-96
-7% -$102K 0.01% 1108
2020
Q4 		$1.27M Sell
1,374
-91
-6% -$95.7K 0.01% 1025
2020
Q3 		$1.51M Hold
1,465
– – 0.02% 845
2020
Q2 		$1.48M Buy
1,465
+75
+5% +$69.6K 0.02% 855
2020
Q1 		$1.21M Hold
1,390
– – 0.02% 821
2019
Q4 		$1.49M Hold
1,390
– – 0.02% 925
2019
Q3 		$1.28M Hold
1,390
– – 0.01% 957
2019
Q2 		$1.57M Buy
1,390
+56
+4% +$61.3K 0.02% 917
2019
Q1 		$1.81M Hold
1,334
– – 0.02% 858
2018
Q4 		$1.54M Buy
1,334
+44
+3% +$49.5K 0.02% 868
2018
Q3 		$1.96M Sell
1,290
-74
-5% -$114K 0.02% 869
2018
Q2 		$2.13M Buy
1,364
+116
+9% +$151K 0.03% 771
2018
Q1 		$1.44M Hold
1,248
– – 0.02% 878
2017
Q4 		$1.48M Buy
+1,248
New +$1.56M 0.02% 874

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

MetLife Investment Management's KYNB Position: Q2 2024 in Review

MetLife Investment Management sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 1,200 shares — an estimated $70.5K sold.

MetLife Investment Management first reported a position in KYNB in Q4 2017 and held it in 24 quarters. The position peaked at $2.13M in Q2 2018. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.

  • MetLife Investment Management reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
  • MetLife Investment Management sold 1,200 Kyntra Bio shares in Q2 2024, an estimated $70.5K.
  • MetLife Investment Management first reported a position in Kyntra Bio in Q4 2017 and held it in 24 quarters.
  • MetLife Investment Management's Kyntra Bio position peaked at $2.13M in Q2 2018.
  • 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.

Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.